The store will not work correctly when cookies are disabled.
2-(imidazo[1,2-a]pyridin-6-yl)-N-(2-methoxyethyl)imidazo[1,2-a]pyrazin-3-amine
ID: ALA4528417
PubChem CID: 155544881
Max Phase: Preclinical
Molecular Formula: C16H16N6O
Molecular Weight: 308.35
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COCCNc1c(-c2ccc3nccn3c2)nc2cnccn12
Standard InChI: InChI=1S/C16H16N6O/c1-23-9-6-19-16-15(20-14-10-17-4-8-22(14)16)12-2-3-13-18-5-7-21(13)11-12/h2-5,7-8,10-11,19H,6,9H2,1H3
Standard InChI Key: YTFFDBDBSPHEHI-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 26 0 0 0 0 0 0 0 0999 V2000
19.3064 -12.0526 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1375 -11.2454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3519 -10.9901 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6979 -12.6074 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9127 -12.3560 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.7368 -11.5398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9062 -11.4549 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.5686 -12.2185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1907 -12.7754 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3458 -13.0935 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.7591 -11.8201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0927 -12.3078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4298 -12.3078 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.1706 -13.0910 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.7188 -13.7049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.5262 -13.5369 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.7826 -12.7495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2327 -12.1389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7579 -10.9934 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.4732 -10.5789 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1889 -10.9878 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9021 -10.5769 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.9028 -9.7502 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 6 1 0
5 4 1 0
4 1 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 5 1 0
10 14 2 0
13 11 1 0
11 12 2 0
12 10 1 0
13 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
11 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
12 1 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 308.35 | Molecular Weight (Monoisotopic): 308.1386 | AlogP: 2.10 | #Rotatable Bonds: 5 |
Polar Surface Area: 68.75 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 6.08 | CX LogP: -0.12 | CX LogD: -0.14 |
Aromatic Rings: 4 | Heavy Atoms: 23 | QED Weighted: 0.57 | Np Likeness Score: -2.15 |
References
1. (2018) Inhibitors of trim33 and methods of use, |